Related Experiment Video
Updated: Sep 28, 2026

Manipulation of Gene Function in Mexican Cavefish
Published on: April 22, 2019
Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia
I O Ebrahim1, M K Sharief, S de Lacy
1Sleep Disorders Centre, Lane Fox Unit, St Thomas's Hospital, Lambeth Palace Road, London, SE1 7EH, UK. irshaadoebrahim@aol.com
Abstract:
The discovery that hypocretins are involved in narcolepsy, a disorder associated with excessive daytime sleepiness, cataplexy, and unusually rapid transitions to rapid eye movement sleep, opens a new field of investigation in the area of disorders of sleep and activation. Hypocretin-1 (hcrt-1) and hypocretin-2 (hcrt-2) (also called orexin-A and orexin-B) are newly discovered neuropeptides processed from a common precursor. Hypocretin containing cells are located exclusively in the lateral hypothalamus, with widespread projections within the central nervous system. The role of the hypocretin system in other disorders causing excessive daytime sleepiness is more uncertain. This study reports the findings of a prospective study measuring cerebrospinal fluid concentrations of hypocretin-1 and hypocretin-2 in HLA DQB1*0602 positive narcolepsy with cataplexy, monosymptomatic narcolepsy, and primary hypersomnia. The results confirmed the previous observations, that hcrt-1 is deficient in narcolepsy and for the first time report very low levels of hcrt-1 in primary hypersomnia. It is also reported for the first time that there is a generalised defect in hcrt-2 transmission in all three of these clinical entities compared with controls.
Insights
Cerebrospinal fluid hypocretin-1 (hcrt-1) is deficient in narcolepsy and primary hypersomnia. This study also found generalized hypocretin-2 (hcrt-2) transmission defects in these sleep disorders.
Area of Science:
- Neuroscience
- Sleep Medicine
- Endocrinology
Background:
- Hypocretins (orexin-A/B) are neuropeptides involved in regulating sleep and activation.
- Hypocretin deficiency is linked to narcolepsy, characterized by excessive daytime sleepiness and cataplexy.
- The role of hypocretins in other hypersomnolence disorders remains less understood.
Purpose of the Study:
- To prospectively measure cerebrospinal fluid (CSF) hypocretin-1 (hcrt-1) and hypocretin-2 (hcrt-2) levels.
- To investigate hypocretin levels in narcolepsy with cataplexy, monosymptomatic narcolepsy, and primary hypersomnia.
- To compare hypocretin levels in these disorders with healthy controls.
Main Methods:
- Prospective study design.
- Measurement of CSF hypocretin-1 and hypocretin-2 concentrations.
- Inclusion of patients with narcolepsy (with and without cataplexy) and primary hypersomnia.
- Comparison with control groups.
Main Results:
- Confirmed hypocretin-1 (hcrt-1) deficiency in narcolepsy.
- Reported significantly low hypocretin-1 (hcrt-1) levels in primary hypersomnia for the first time.
- Observed generalized hypocretin-2 (hcrt-2) transmission defects across all studied clinical entities compared to controls.
Conclusions:
- Hypocretin-1 (hcrt-1) deficiency is a key feature in narcolepsy and primary hypersomnia.
- Hypocretin-2 (hcrt-2) transmission is impaired in these disorders.
- These findings highlight the broader involvement of the hypocretin system in hypersomnolence disorders.
Related Concept Videos
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Narcolepsy
REM Sleep Behavior Disorder
RBD is significantly associated with...
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
